Retinal pigment epithelium melanin and ocular toxicity

International Journal of Toxicology

Volumn 21, Issue 6, 2002, Pages 451-454

  Dayhaw Barker, Pierrette ^a  

^a PENNSYLVANIA COLLEGE OF OPTOMETRY   (United States)

Author keywords

Carotenoids; Drug Binding; Melanin; Ocular Transmittance; Retinal Pigment Epithelium (RPE)

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTIMALARIAL AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLOROQUINE; CHLORPROMAZINE; CYCLOPLEGIC AGENT; EPHEDRINE; HYDROXYCHLOROQUINE; MELANIN; MYDRIATIC AGENT; NEUROLEPTIC AGENT; OXYGEN RADICAL; PHENOTHIAZINE DERIVATIVE; PHOTOSENSITIZING AGENT; QUINOLONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; TIMOLOL; TROPICAMIDE;

BLINDNESS; CHOROID; CONFERENCE PAPER; DRUG BINDING; EYE TOXICITY; HISTOCHEMISTRY; HORMONE BINDING; HUMAN; LIGHT; NERVE CELL; PATHOGENESIS; PHOTORECEPTOR; PHOTOTOXICITY; PHOTOTRANSDUCTION; PIGMENT EPITHELIUM; RADIATION; RETINA; RETINOPATHY; VISION;

EYE DISEASES; HUMANS; MELANINS; OCULAR PHYSIOLOGY; PHARMACEUTICAL PREPARATIONS; PIGMENT EPITHELIUM OF EYE; PROTEIN BINDING; RETINA; RETINAL PIGMENTS;

EID: 0036952580     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1080/10915810290169873     Document Type: Conference Paper

References (28)

1. Barker, F. M., and G. C. Brainard. 1991. The direct spectral transmittance of the excised human lens as a function of age. U.S. Food and Drug Administration Report.
2. Boulton, M. 1998. The role of melanin in the RPE. In The retinal pigment epithelium, eds. M. Marmor and T. Wolfensberger, 68-85. Oxford, UK: Oxford University Press.
3. Boulton, M., and P. Dayhaw-Barker. 2001. The role of the RPE: Topographical variation and ageing changes. Eye 15:384-389.
4. Boulton, M., F. Docchio, P. Dayhaw-Barker, R. Ramponi, and R. Cubeddu. 1990. Age-related changes in the morphology, absorption and fluorescence of melanosomes and lipofuscin granules of the retinal pigment epithelium. Vision Res. 9:1291-1303.
5. Boulton, M., M. Rozanoswska, and B. Rozanowski. 2001. Retinal photodamage. J. Photochem. Photobiol. 64:144-161.
6. Dayhaw-Barker P., D. F. Forbes, D. Fox, S. Lerman, J. McGuiness, M. Waxler, and R. Felten. 1986. Drug phototoxicity and visual health. In Optical radiation and visual health, eds. M. Waxler and V. Hutchins, 148-175. Boca Raton, FL: CRC Press.
7. Dayhaw-Barker, P., W. Under, E. Bouma, and M. Boulton. 1988. Binding characteristics of drugs to melanin granules from human RPE. Invest. Ophthalmol. Vis. Res. 29S:285.
8. German, E. J., D. Wood, and M. A. Hurst. 1999. Ocular effects of antimuscafinic compounds: Is clinical effect determined by binding affinity for muscarinic receptor or melanin pigment? J. Ocul. Pharmacol. Ther. 15:257-269.
9. Grimm, C., C. E. Reme, P. O. Rol, and T. P. Williams. 2000. Blue light's effect on rhodopsin: Photoreversal of bleaching in living rat eyes. Invest. Ophthalmol. Vis. Sci. 12:3984-3990.
10. Ham, W. T., Jr., H. A. Mueller, J. J. Ruffolo Jr., D. Guerry 3rd, and R. K. Guerry. 1982. Action spectrum for retinal injury from near-ultraviolet radiation in the aphakic monkey. Am. J. Ophthalmol. 93:299-306.
11. Handleman, G. J., and E. A. Dratz. 1986. The role of antioxidants in the retina and retinal pigment epithelium and the nature of pro-oxidant induced damage. Adv. Free Radic. Biol. 2:1-89.
12. Hill, H. Z., W. J. Li, P. Xin, and D. L. Mitchell. 1997. Melanin: A two-edged sword. Pigment Cell Res. 10:158-161.
13. Landrum, J. T., and R. A. Bone. 2001. Lutein, zeaxanthin and the macular pigment. Arch. Biochem. Biophys. 385:28-40.
14. Larrson, B., and H. Tjalve. 1979. Studies on the mechanism of drug binding to melanin. Biochem. Pharmacol. 28:1181-1187.
15. Larrson, B. S. 1993. Interaction between chemicals and melanin. Pigment Cell Res. 6:127-133.
16. Parver, L. M. 2000. Photochemical injury to the foveamacula of the monkey eye following argon blue green panretinal photocoagulation. Trans. Am. Ophthalmol. Soc. 98:365-374.
17. Potts, A. M. 1962. The concentration of phenothiazides in the eye of experimental animals. Invest. Ophthalmol. 1:521-523.
18. Prota, G., D. N. Hu, M. R. Vincensi, S. A. McCormick, and A. Napolitano. 1998. Characterization of melanins in human irides and cultures of uveal melanocytes from eyes of different colors. Exp. Eye Res. 67:293-299.
19. Salazar-Bookaman, M. M., I. Wainer, and P. N. Patil. 1994. Relevance of drug-melanin interactions to ocular pharmacology and toxicology. J. Ocul. Pharmacol. 10:217-239.
20. Sarna, T., and R. C. Sealy. 1984. Free radicals from eumelanin: Quantum yield and wavelength dependence. Arch. Biochem. Biophys. 232:574-578.
21. Schalch, W., P. Dayhaw-Barker, and F. M. Barker II. 1999. The carotenoids of the human eye. In Nutritional and environmental influences on the eye, ed. A, Taylor, 215-250. Boca Raton, FL: CRC Press.
22. Schraermeyer, U., and K. Heimann. 1999. Current understanding on the role of retinal pigment epithelium and its pigmentation. Pigment Cell Res. 12:219-236.
23. Smith-Thomas, L., P. Richardson, A. J. Thody, A. Graham, I. Palmer, L. Flemming, M. A. Parsons, I. G. Rennie, and S. MacNeil. 1996. Human ocular melanocytes and retinal pigment epithelium differ in their melanogenic properties in vivo and in vitro. Curr. Eye Res. 15:1079-1091.
24. Sparrow, J. R., K. Nakanishi, and C. A. Parrish. 2000. The lipofuscin fluorophore A2E mediates blue light induced damage to retinal pigmented cells. Invest. Ophthalmol. Vis. Sci. 41:1981-1989.
25. Stepien, K. B., and T. Wilczok. 1982. Studies on the mechanism of chloroquine binding to synthetic DOPA melanin. Biochem. Pharmacol. 31:3359-3365.
26. Suter, M., C. Reme, C. Grimm, A. Wenzel, M. Jaattela, P. Esser, N. Kociok, M. Leist, and C. Richert. 2000. Age-related macular degeneration. J. Biol. Chem. 275:39625-39630.
27. Szel, A., and P. Rohlich. 1988. The mosaic of colour-specific photoreceptors in the mammalian retina as defined by immunocytochemistry. Acta Morphol. Hung. 36:191-202.
28. Tikellis, G., L. D. Robman, C. A. Harper, S. K. Garrett, J. J. McNeil, H. R. Taylor, and C. A. McCarty. 1999. The VECAT study: Methodology and statistical power for measurement of age-related macular features. Vitamin E, cataract and age-related maculopathy study. Ophthal. Epidemiol. 6:181-194.